blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4340818

EP4340818 - PHARMACEUTICAL TABLET COMPRISING ACETYLSALICYLIC ACID [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  23.02.2024
Database last updated on 16.09.2024
FormerThe international publication has been made
Status updated on  26.11.2022
Formerunknown
Status updated on  20.02.2022
Most recent event   Tooltip26.07.2024Change: Validation statespublished on 28.08.2024  [2024/35]
26.07.2024Change - extension statespublished on 28.08.2024  [2024/35]
Applicant(s)For all designated states
G.L. Pharma GmbH
Schlossplatz 1
8502 Lannach / AT
[2024/13]
Inventor(s)01 / LEITNER, Joachim
8502 Lannach / AT
 [2024/13]
Representative(s)SONN Patentanwälte GmbH & Co KG
Riemergasse 14
1010 Wien / AT
[2024/13]
Application number, filing date22703640.703.02.2022
[2024/13]
WO2022EP52606
Priority number, dateEP2021017465219.05.2021         Original published format: EP 21174652
[2024/13]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022242919
Date:24.11.2022
Language:EN
[2022/47]
Type: A1 Application with search report 
No.:EP4340818
Date:27.03.2024
Language:EN
The application published by WIPO in one of the EPO official languages on 24.11.2022 takes the place of the publication of the European patent application.
[2024/13]
Search report(s)International search report - published on:EP24.11.2022
ClassificationIPC:A61K9/28, A61K31/00
[2024/13]
CPC:
A61K9/2846 (EP); A61K31/616 (EP); A61K9/2893 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/13]
TitleGerman:PHARMAZEUTISCHE TABLETTE ENTHALTEND ACETYLSALICYLSÄURE[2024/13]
English:PHARMACEUTICAL TABLET COMPRISING ACETYLSALICYLIC ACID[2024/13]
French:COMPRIMÉ PHARMACEUTIQUE COMPRENANT DE L'ACIDE ACÉTYLSALICYLIQUE[2024/13]
Entry into regional phase09.11.2023National basic fee paid 
09.11.2023Designation fee(s) paid 
09.11.2023Examination fee paid 
Examination procedure09.11.2023Amendment by applicant (claims and/or description)
09.11.2023Examination requested  [2024/13]
09.11.2023Date on which the examining division has become responsible
Fees paidRenewal fee
08.02.2024Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]AU477515B  (STERLING PHARMACEUTICALS PTY. LIMITED) [X] 1,3,5,8 * embodiment 1 *;
 [A]US4716042  (BLANK ROBERT G [US], et al) [A] 1-8 * example 1 *;
 [XI]CN101596166B  (YUNG SHIN PHARM IND KUNSHAN CO LTD) [X] 1-3,5,7,8 * page 7 * [I] 4,6;
 [A]US2012015032  (KIM SUNG WUK [KR], et al) [A] 1-8 * figure 13; example 2 *;
 [A]  - Sims Elizabeth ET AL, "Eye on excipients", (20160401), pages 1 - 3, URL: https://tabletscapsules.com/wp-content/uploads/pdf/tc_20160301_0047.pdf, (20211101), XP055856618 [A] 1-8 * page 1; figure 1 * * page 3; figure 5 *
by applicantUS4716042
 US2012015032
 EP2785331
 EP3027176
 EP2811985
    - BRIGDEN M.SMITH R. E., Can Med Assoc J, (19970000), vol. 156, pages 1025 - 8
    - ARONOFF D. M.NEILSON E. G., Am J Med, (20010000), vol. 111, no. 4, pages 304 - 15
    - UNDAS et al., J Thromb Haemost, (20140000), vol. 12, pages 1776 - 87
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.